bf/NASDAQ:EYES_icon.png

NASDAQ:EYES

Second Sight Medical Products, Inc.

  • Stock

USD

Last Close

4.36

31/08 04:00

Market Cap

210.05M

Beta: 2.56

Volume Today

35.77K

Avg: -

PE Ratio

−10.28

PFCF: −40.28

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-22.97M
-
-35.20M
53.26%
-20.02M
43.13%
-33.18M
65.75%
-28.52M
14.05%
-35.09M
23.07%
-33.59M
4.28%
-14.88M
55.70%
-8.92M
40.05%
depreciation and amortization
315.77K
-
279.18K
11.59%
335K
19.99%
432K
28.96%
457K
5.79%
435K
4.81%
397K
8.74%
164K
58.69%
70K
57.32%
deferred income tax
stock based compensation
769.90K
-
1.47M
91.54%
2.69M
82.21%
3.37M
25.31%
3.78M
12.38%
3.59M
5.15%
2.92M
18.50%
421K
85.61%
75K
82.19%
change in working capital
-557.22K
-
1.60M
386.74%
-3.88M
342.65%
-950K
75.50%
3.31M
448.84%
425K
87.18%
37K
91.29%
-3.74M
10,218.92%
-421K
88.76%
accounts receivables
-148.31K
-
-239.00K
61.15%
-793K
231.79%
955K
220.43%
-1.41M
247.96%
1.22M
186.34%
48K
96.07%
461K
860.42%
inventory
-559.89K
-
-3.38M
502.84%
-2.49M
26.29%
10K
100.40%
3.87M
38,580%
-1.18M
130.46%
-347K
70.54%
529K
252.45%
accounts payables
-417.05K
-
198.78K
147.66%
197K
0.89%
446K
126.40%
-419K
193.95%
554K
232.22%
-213K
138.45%
-1.05M
393.43%
63K
105.99%
other working capital
568.03K
-
5.01M
782.57%
-793K
115.82%
-2.36M
197.73%
1.28M
154.13%
-171K
113.38%
549K
421.05%
-3.68M
770.86%
-484K
86.86%
other non cash items
5.01M
-
14.76M
194.34%
324K
97.80%
5.26M
1,523.46%
-2.99M
156.77%
835K
127.96%
2.60M
211.86%
1.22M
53.26%
9K
99.26%
net cash provided by operating activities
-17.43M
-
-17.09M
1.92%
-20.55M
20.22%
-25.07M
22.00%
-23.95M
4.48%
-29.81M
24.48%
-27.63M
7.32%
-16.82M
39.11%
-9.19M
45.38%
investments in property plant and equipment
-246.00K
-
-560.35K
127.78%
-762K
35.99%
-490K
35.70%
-265K
45.92%
-163K
38.49%
-493K
202.45%
-330K
33.06%
-14K
95.76%
acquisitions net
purchases of investments
-4.30M
-
-25.39M
490.20%
sales maturities of investments
18.28M
-
5.38M
70.58%
3.11M
42.25%
other investing activites
398K
-
net cash used for investing activites
-4.55M
-
-25.95M
470.60%
17.52M
167.51%
4.89M
72.10%
2.84M
41.88%
-163K
105.74%
-493K
202.45%
68K
113.79%
-14K
120.59%
debt repayment
-53.67K
-
common stock issued
2.40M
-
43.29M
1,703.43%
272K
-
262K
3.68%
25.94M
9,799.24%
34.51M
33.04%
6.68M
80.64%
77.79M
1,064.68%
common stock repurchased
dividends paid
other financing activites
19.63M
-
509.35K
97.40%
2.76M
441.67%
20.18M
631.42%
20.91M
3.60%
665K
96.82%
484K
27.22%
1.92M
296.49%
-2.17M
213.24%
net cash used provided by financing activities
21.97M
-
43.80M
99.34%
2.76M
93.70%
20.45M
641.28%
21.17M
3.50%
26.60M
25.67%
34.99M
31.53%
8.60M
75.43%
75.62M
779.46%
effect of forex changes on cash
-82.36K
-
-206.47K
150.68%
-107K
48.18%
30K
128.04%
3K
90%
4K
33.33%
-11K
375%
6K
154.55%
2K
66.67%
net change in cash
-82.19K
-
556.85K
777.52%
-380K
168.24%
300K
178.95%
65K
78.33%
-3.37M
5,281.54%
6.86M
303.56%
-8.15M
218.87%
66.42M
914.92%
cash at beginning of period
144.75K
-
62.56K
56.78%
619K
889.37%
239K
61.39%
539K
125.52%
7.84M
1,354.36%
4.47M
42.96%
11.33M
153.34%
3.18M
71.95%
cash at end of period
62.56K
-
619.41K
890.03%
239K
61.41%
539K
125.52%
604K
12.06%
4.47M
640.23%
11.33M
153.34%
3.18M
71.95%
69.59M
2,090.53%
operating cash flow
-17.43M
-
-17.09M
1.92%
-20.55M
20.22%
-25.07M
22.00%
-23.95M
4.48%
-29.81M
24.48%
-27.63M
7.32%
-16.82M
39.11%
-9.19M
45.38%
capital expenditure
-246.00K
-
-560.35K
127.78%
-762K
35.99%
-490K
35.70%
-265K
45.92%
-163K
38.49%
-493K
202.45%
-330K
33.06%
-14K
95.76%
free cash flow
-17.67M
-
-17.65M
0.11%
-21.31M
20.72%
-25.56M
19.94%
-24.21M
5.27%
-29.97M
23.79%
-28.12M
6.18%
-17.15M
39.01%
-9.20M
46.35%

All numbers in USD (except ratios and percentages)